Visualitza per autor "Kim, Tae Won"
Ara mostrant els elements 1-4 d 4
-
Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial
Kim, Tae Won; LoRusso, Patricia; Gordon, Michael; Bendell, Johanna ; OH, DO-YOUN; Bedard, Philippe; GARRALDA, Elena (American Medical Association, 2023-11) -
Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial
Chibaudel, Benoist; Henriques, Julie; Rakez, Manel; Brenner, Baruch; Kim, Tae Won; Martínez-Villacampa, Mercedes; Tabernero Caturla, Josep (American Medical Association, 2020-10-19) -
Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer
Kim, Tae Won; Yong, Wei Peng; Shiu, Kai-Keen; Vittrup, Benny; Elez Fernandez, Mª Elena; Yoshino, Takayuki; André, Thierry (Wiley, 2023-03) -
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164
Le, Dung T.; Kim, Tae Won; Van Cutsem, Eric; Geva, Ravit; Jäger, Dirk; Hara, Hiroki; Elez Fernandez, Mª Elena (American Society of Clinical Oncology, 2020-01-01)